Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]:
SEC Accession No. 0001193125-14-072014
Filing Date
2014-02-27
Accepted
2014-02-27 12:37:08
Documents
6
Effectiveness Date
2014-02-27

Document Format Files

Seq Description Document Type Size
1 SUPPLEMENT d685450dsuppl.htm SUPPL 342065
2 GRAPHIC g685450g34w23.jpg GRAPHIC 27333
3 GRAPHIC g685450g55t09.jpg GRAPHIC 55197
4 GRAPHIC g685450g61u08.jpg GRAPHIC 3594
5 GRAPHIC g685450g72m57.jpg GRAPHIC 13114
6 GRAPHIC g685450g89q14.jpg GRAPHIC 88455
  Complete submission text file 0001193125-14-072014.txt   602407
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SUPPL | Act: 98 | File No.: 333-182260 | Film No.: 14647628
SIC: 2834 Pharmaceutical Preparations